3043 companies

Verrica Pharmaceuticals

Market Cap: US$39.5m

A dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States.

VRCA

US$4.18

7D

-4.8%

1Y

-75.3%

GeneMatrix

Market Cap: ₩55.5b

Develops diagnostic products for various diseases in the field of molecular diagnostics.

A109820

₩2,720.00

7D

-16.2%

1Y

-20.6%

BioAtla

Market Cap: US$39.3m

A clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

BCAB

US$0.67

7D

7.6%

1Y

-59.0%

Haleos Labs

Market Cap: ₹3.5b

Engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.

SMSLIFE

₹1,149.20

7D

-3.0%

1Y

-21.0%

NPTLtd

Market Cap: JP¥5.8b

Engages in clinical development of new drugs and treatments for personalized medicines.

311A

JP¥1,200.00

7D

0%

1Y

n/a

Pharmedic Pharmaceutical Medicinal

Market Cap: ₫1.0t

Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.

PMC

₫110,000.00

7D

0%

1Y

26.7%

Adaptimmune Therapeutics

Market Cap: US$39.0m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

ADAP

US$0.15

7D

1.8%

1Y

-85.0%

Bio Preventive Medicine

Market Cap: NT$1.2b

Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases.

6810

NT$24.00

7D

-0.6%

1Y

-24.8%

Tdspharm

Market Cap: ₩54.8b

Researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally.

A464280

₩9,910.00

7D

-2.9%

1Y

-52.1%

Trident Lifeline

Market Cap: ₹3.4b

Manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally.

543616

₹296.00

7D

2.1%

1Y

-7.1%

J2KBIO

Market Cap: ₩54.5b

A bio venture company, provides active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation.

A420570

₩9,320.00

7D

-4.4%

1Y

-50.8%

Mabion

Market Cap: zł140.8m

A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.

MAB

zł8.71

7D

-6.3%

1Y

-48.5%

Precision System Science

Market Cap: JP¥5.8b

Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.

7707

JP¥212.00

7D

-0.5%

1Y

-24.3%

Eagle Veterinary TechnologyLtd

Market Cap: ₩54.1b

Manufactures and sells animal health care products.

A044960

₩4,280.00

7D

-0.8%

1Y

-14.7%

Annovis Bio

Market Cap: US$38.4m

A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.

ANVS

US$1.97

7D

-15.1%

1Y

-75.7%

Lyka Labs

Market Cap: ₹3.4b

A pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India.

LYKALABS

₹94.85

7D

-5.6%

1Y

-35.5%

Navamedic

Market Cap: NOK 379.7m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

NAVA

NOK 21.50

7D

-1.8%

1Y

-29.5%

Cytogen

Market Cap: ₩53.5b

A biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea.

A217330

₩2,320.00

7D

-5.7%

1Y

-67.2%

Pluri

Market Cap: US$37.9m

A biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries.

PLUR

US$4.65

7D

1.1%

1Y

-23.5%

GW VitekLTD

Market Cap: ₩53.9b

Engages in the development, manufacturing, and sale of bio-related antibodies and biotechnology solutions in Korea, the United States, Asia, Europe, and internationally.

A036180

₩577.00

7D

0%

1Y

-20.3%

Corline Biomedical

Market Cap: SEK 356.3m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

CLBIO

SEK 14.55

7D

-2.0%

1Y

83.7%

Mersana Therapeutics

Market Cap: US$37.8m

A clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs.

MRSN

US$7.57

7D

4.4%

1Y

-83.6%

Liminatus Pharma

Market Cap: US$37.7m

Operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies.

LIMN

US$1.45

7D

15.1%

1Y

-86.5%

Rekah Pharmaceutical Industry

Market Cap: ₪126.1m

Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.

REKA

₪11.05

7D

-0.5%

1Y

-18.1%

Proteomics International Laboratories

Market Cap: AU$57.3m

Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia.

PIQ

AU$0.35

7D

0%

1Y

-50.0%

Novacyt

Market Cap: €31.9m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

ALNOV

€0.45

7D

-1.3%

1Y

-39.4%

Extrawell Pharmaceutical Holdings

Market Cap: HK$290.7m

An investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong.

858

HK$0.11

7D

-1.7%

1Y

245.5%

Intervacc

Market Cap: SEK 348.3m

Develops novel veterinary vaccines for animals in Sweden.

IVACC

SEK 1.02

7D

-3.8%

1Y

-70.6%

Lukas Biomedical

Market Cap: NT$1.1b

Engages in the wholesale and retail of cosmetics in Taiwan.

6814

NT$26.80

7D

1.7%

1Y

-11.3%

C21 Investments

Market Cap: CA$51.2m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

CXXI

CA$0.43

7D

-6.5%

1Y

47.5%

Provectus Biopharmaceuticals

Market Cap: US$36.7m

A clinical-stage biotechnology company, engages in developing immunotherapy medicines for various diseases in the United States.

PVCT

US$0.087

7D

34.5%

1Y

-10.5%

IGC Pharma

Market Cap: US$36.6m

A clinical stage pharmaceutical company, develops treatments for Alzheimer’s disease in the United States and Colombia.

IGC

US$0.40

7D

-2.8%

1Y

12.3%

Nectar Lifesciences

Market Cap: ₹3.2b

Manufactures, distributes, markets and sells pharmaceutical products in India and internationally.

NECLIFE

₹14.42

7D

-9.8%

1Y

-64.8%

Poolbeg Pharma

Market Cap: UK£27.2m

A clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom.

POLB

UK£0.039

7D

-1.3%

1Y

-59.4%

MegaPro Biomedical

Market Cap: NT$1.1b

A biotech company, focuses on the development of nano drugs.

6827

NT$17.15

7D

-3.1%

1Y

0.3%

Sonnet BioTherapeutics Holdings

Market Cap: US$36.4m

A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.

SONN

US$5.33

7D

-14.0%

1Y

-6.1%

Page 53 of 85